Skip to main content
Top

Calcified Tissue International

Issue 5/2000

Content (13 Articles)

Ultrasound Bone Densitometry of the Os Calcis in Children and Adolescents

K. Wünsche, B. Wünsche, H. Fähnrich, H.-J. Mentzel, S. Vogt, K. Abendroth, W. A. Kaiser

Longitudinal Study of Bone Density and its Determinants in Women in Peri- or Early Menopause

D. Picard, A. Imbach, M. Couturier, R. Lepage, L-G Ste-Marie

Association of CTR and COLIA1 Alleles with BMD Values in Peri- and Postmenopausal Women

V. Braga, M. Mottes, S. Mirandola, V. Lisi, G. Malerba, L. Sartori, G. Bianchi, D. Gatti, M. Rossini, D. Bianchini, S. Adami

Effects of Pregnancy and Lactation on Trabecular Bone and Marrow Adipocytes in Rats

A. Honda, T. Kurabayashi, T. Yahata, M. Tomita, H. Matsushita, K. Takakuwa, K. Tanaka

p21 and Parathyroid Hormone-Related Peptide in the Growth Plate

M. Zenmyo, S. Komiya, T. Hamada, K. Hiraoka, R. Suzuki, A. Inoue

Morphological and Functional Features of Clasts in Low Phosphate, Vitamin D-Deficiency Rickets

J. Nordahl, K. Hollberg, S. Mengarelli-Widholm, G. Andersson, F. P. Reinholt

Apatite Mineralization in Teeth of the Chiton Acanthopleura echinata

A. P. Lee, L. R. Brooker, D. J. Macey, W. van Bronswijk, J. Webb

Letter to the Editor

Zinc, a New Coherent Therapy for Osteoporosis?

H. Rico, L. F. Villa

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine